By Felix Onuah
ABUJA, Jan 5 (Reuters) - Nigeria hopes to get 42 million
COVID-19 vaccines to cover one-fifth of its population through
the global COVAX scheme, said Faisal Shuaib, head of the
country's primary healthcare agency, on Tuesday.
Shuaib said the batch of vaccines would come as part of
Nigeria's plan to inoculate 40% of the population this year,
with another 30% in 2022. By the end of January, 100,000 doses
of the Pfizer-BioNTech PFE.N BNTX.O vaccine are expected to
arrive, he said.
The COVAX scheme was set up to provide vaccines to poorer
countries such as Nigeria, whose 200 million people and poor
infrastructure pose a daunting challenge to medical officials
rolling out the vaccinations as the West African country battles
a second, larger spike in coronavirus cases.
Nigeria, where officials recorded low coronavirus numbers
through much of 2020, had 1,204 new cases on Monday, its highest
ever, as total confirmed cases edged closer to 100,000.
(Graphic: https://tmsnrt.rs/34pvUyi)
Nigeria will first inoculate frontline health workers, first
responders, national leaders, people vulnerable to coronavirus
and the elderly, Shuaib said during a regular COVID-19 briefing
in the capital Abuja.
He also underscored popular resistance to vaccines and said
Nigeria must educate people on their importance.
"We fear what we don't understand," said Shuaib.
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
GRAPHIC-COVID-19 global tracker https://tmsnrt.rs/34pvUyi
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>